Testing effectiveness (Phase 2)Ended earlyNCT01061580What this trial is testingBMAC Enhanced Coronary Artery Bypass Grafting (CABG)Who this might be right forCongestive Heart Failure Harvest Technologies 20
Testing effectiveness (Phase 2)Ended earlyNCT00720629What this trial is testingVisilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationWho this might be right forGraft Versus Host Disease H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Very early researchEnded earlyNCT03546556What this trial is testing18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant PatientsWho this might be right forGraft Vs Host Disease UNC Lineberger Comprehensive Cancer Center 10
Not applicableNot Yet RecruitingNCT02558452What this trial is testingEuropean Transplant Registry of Senior Renal Transplant Recipients on AdvagrafWho this might be right forGraft FailureDeathAcute Rejection of Renal Transplant+7 more Klemens Budde 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03924401What this trial is testingAcute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantWho this might be right forGraft Versus Host Disease Emory University 30
Not applicableStudy completedNCT00056784What this trial is testingThe Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ TransplantationWho this might be right forKidney Transplantation National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06607367What this trial is testingREscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2Who this might be right forPoor Graft FunctionAplastic Anemia Idiopathic Melbourne Health 20
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Large-scale testing (Phase 3)Looking for participantsNCT03818334What this trial is testingPost Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesWho this might be right forBone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection Viral+2 more Hospital Israelita Albert Einstein 50
Not applicableStudy completedNCT06131541What this trial is testingRidge Splitting With Implant Placement Using Autogenous Tooth GraftWho this might be right forDental Implant Failure NosAlveolar Bone LossPeri-Implantitis Kafrelsheikh University 52
Not applicableNo Longer AvailableNCT01200017What this trial is testingExpanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more Christopher Dvorak
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Not applicableStudy completedNCT03188601What this trial is testingΑ1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHDWho this might be right forGVHDBone Marrow Transplant FailureAlpha 1-Antitrypsin Rambam Health Care Campus 27
Testing effectiveness (Phase 2)Study completedNCT02256501What this trial is testingIntracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric CardiomyopathyWho this might be right forCardiomyopathy Nasser Aghdami MD., PhD 30
Testing effectiveness (Phase 2)Study completedNCT00615394What this trial is testingAutologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-ThoracotomyWho this might be right forDilated Cardiomyopathy Instituto de Cardiologia do Rio Grande do Sul 6
Testing effectiveness (Phase 2)Study completedNCT01010217What this trial is testingMismatched Transplantation Using High-dose Post-transplant CyclophosphamideWho this might be right forBlood Stem Cell Transplant FailureLeukemiaHematologic Malignancies M.D. Anderson Cancer Center 176
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Large-scale testing (Phase 3)UnknownNCT01693042What this trial is testingCompare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart FailureWho this might be right forHeart Failure Johann Wolfgang Goethe University Hospital 81